These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 33528293)

  • 21. Sandwiched White Adipose Tissue: A Microphysiological System of Primary Human Adipose Tissue.
    Lau FH; Vogel K; Luckett JP; Hunt M; Meyer A; Rogers CL; Tessler O; Dupin CL; St Hilaire H; Islam KN; Frazier T; Gimble JM; Scahill S
    Tissue Eng Part C Methods; 2018 Mar; 24(3):135-145. PubMed ID: 29141507
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterizing the reproducibility in using a liver microphysiological system for assaying drug toxicity, metabolism, and accumulation.
    Rubiano A; Indapurkar A; Yokosawa R; Miedzik A; Rosenzweig B; Arefin A; Moulin CM; Dame K; Hartman N; Volpe DA; Matta MK; Hughes DJ; Strauss DG; Kostrzewski T; Ribeiro AJS
    Clin Transl Sci; 2021 May; 14(3):1049-1061. PubMed ID: 33382907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research and Development of Microphysiological Systems in Japan Supported by the AMED-MPS Project.
    Ishida S
    Front Toxicol; 2021; 3():657765. PubMed ID: 35295097
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Growth of human breast tissues from patient cells in 3D hydrogel scaffolds.
    Sokol ES; Miller DH; Breggia A; Spencer KC; Arendt LM; Gupta PB
    Breast Cancer Res; 2016 Mar; 18(1):19. PubMed ID: 26926363
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Human decellularized adipose tissue scaffold as a model for breast cancer cell growth and drug treatments.
    Dunne LW; Huang Z; Meng W; Fan X; Zhang N; Zhang Q; An Z
    Biomaterials; 2014 Jun; 35(18):4940-9. PubMed ID: 24661550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Integrated Isogenic Human Induced Pluripotent Stem Cell-Based Liver and Heart Microphysiological Systems Predict Unsafe Drug-Drug Interaction.
    Lee-Montiel FT; Laemmle A; Charwat V; Dumont L; Lee CS; Huebsch N; Okochi H; Hancock MJ; Siemons B; Boggess SC; Goswami I; Miller EW; Willenbring H; Healy KE
    Front Pharmacol; 2021; 12():667010. PubMed ID: 34025426
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organs-on-a-Chip.
    Low LA; Sutherland M; Lumelsky N; Selimovic S; Lundberg MS; Tagle DA
    Adv Exp Med Biol; 2020; 1230():27-42. PubMed ID: 32285363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Synthetic Hydrogel, VitroGel
    Cherne MD; Sidar B; Sebrell TA; Sanchez HS; Heaton K; Kassama FJ; Roe MM; Gentry AB; Chang CB; Walk ST; Jutila M; Wilking JN; Bimczok D
    Front Pharmacol; 2021; 12():707891. PubMed ID: 34552484
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Establishment of a resazurin-based aortic valve tissue viability assay for dynamic culture in a microphysiological system.
    Dittfeld C; Winkelkotte M; Behrens S; Schmieder F; Jannasch A; Matschke K; Sonntag F; Tugtekin SM
    Clin Hemorheol Microcirc; 2021; 79(1):167-178. PubMed ID: 34487029
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Organoid intelligence (OI) - The ultimate functionality of a brain microphysiological system.
    Smirnova L; Morales Pantoja IE; Hartung T
    ALTEX; 2023; 40(2):191-203. PubMed ID: 37009773
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
    Hughes DJ; Kostrzewski T; Sceats EL
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kidney Organoid and Microphysiological Kidney Chip Models to Accelerate Drug Development and Reduce Animal Testing.
    Chen WY; Evangelista EA; Yang J; Kelly EJ; Yeung CK
    Front Pharmacol; 2021; 12():695920. PubMed ID: 34381363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Standing Photo-Crosslinked Hydrogel Construct: in vitro Microphysiological Vascular Model.
    Manigandan A; Amruthavarshini R P; Sethuraman S; Subramanian A
    Cells Tissues Organs; 2022; 211(3):335-347. PubMed ID: 34058730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Progress Report and Roadmap for Microphysiological Systems and Organ-On-A-Chip Technologies to Be More Predictive Models in Human (Knee) Osteoarthritis.
    Rothbauer M; Reihs EI; Fischer A; Windhager R; Jenner F; Toegel S
    Front Bioeng Biotechnol; 2022; 10():886360. PubMed ID: 35782494
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Considerations from an International Regulatory and Pharmaceutical Industry (IQ MPS Affiliate) Workshop on the Standardization of Complex In Vitro Models in Drug Development.
    Tomlinson L; Ramsden D; Leite SB; Beken S; Bonzo JA; Brown P; Candarlioglu PL; Chan TS; Chen E; Choi CK; David R; Delrue N; Devine PJ; Ford K; Garcia MI; Gosset JR; Hewitt P; Homan K; Irrechukwu O; Kopec AK; Liras JL; Mandlekar S; Raczynski A; Sadrieh N; Sakatis MZ; Siegel J; Sung K; Sunyovszki I; Van Vleet TR; Ekert JE; Hardwick RN
    Adv Biol (Weinh); 2023 Oct; ():e2300131. PubMed ID: 37814378
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies.
    Maass C; Dallas M; LaBarge ME; Shockley M; Valdez J; Geishecker E; Stokes CL; Griffith LG; Cirit M
    Sci Rep; 2018 May; 8(1):8015. PubMed ID: 29789564
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Stromal fibroblasts regulate microvascular-like network architecture in a bioengineered breast tumour angiogenesis model.
    Koch MK; Jaeschke A; Murekatete B; Ravichandran A; Tsurkan M; Werner C; Soon P; Hutmacher DW; Haupt LM; Bray LJ
    Acta Biomater; 2020 Sep; 114():256-269. PubMed ID: 32707406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bioengineering embryonic stem cell microenvironments for the study of breast cancer.
    Raof NA; Mooney BM; Xie Y
    Int J Mol Sci; 2011; 12(11):7662-91. PubMed ID: 22174624
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leveraging microphysiological systems to address challenges encountered during development of oligonucleotide therapeutics.
    Ramsden D; Belair DG; Agarwal S; Andersson P; Humphreys S; Dalmas DA; Stahl SH; Maclauchlin C; Cichocki JA
    ALTEX; 2022; 39(2):273–296. PubMed ID: 34766620
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Organs-on-chips: Progress, challenges, and future directions.
    Low LA; Tagle DA
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1573-1578. PubMed ID: 28343437
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.